1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsMaternal and Child Health Services is sponsored by HRSA Maternal & Child Health Bureau. Provides funding for programs that improve maternal and child health, including adolescent sexual and reproductive health services.
Get alerted about grants like this
Save a search for “HRSA Maternal & Child Health Bureau” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
# Maternal and Child Health Services | HRSA U.S. Department of Health & Human ServicesHealth Resources & Services Administration Call, Text, or Chat the Maternal Mental Health Hotline * Scholarships and Loan Repayment for Health Careers * National Maternal Mental Health Hotline * Home Visits for Moms and Children * Ryan White HIV/AIDS Program * Become a Grant Reviewer * Congressionally Directed Spending * Loans & Scholarships Overview * National Health Service Corps * Native Hawaiian Health Scholarship * Nurse Corps Loan Repayment Program * Nurse Corps Scholarship Program * For Schools: Loan Programs * Data Warehouse Overview * Strategic Priority Areas 4.
Maternal and Child Health Services * Apply for a GrantExpandable sidenav button * Prepare Your Application * Follow the Application Process * Manage your GrantExpandable sidenav button * Administrative Management * Policies, Regulations, & Guidance * Grants HelpExpandable sidenav button * Frequently Asked Questions * Become a Grant Reviewer # Maternal and Child Health Services Funding Opportunity Number:HRSA-22-001 Dates to Apply:02/24/2021 to 09/01/2021 Bureau/Office:Maternal & Child Health Bureau Estimated Award Date:10/01/2021 View grant opportunitygrants.
hrsa.
gov The purpose of the Title V MCH Services Block Grant program is to enable each state to: Assure mothers and children access to quality maternal and child health services, especially for those with low-incomes or limited availability of care; Reduce infant mortality; Provide access to prenatal, delivery, and postnatal care to women (especially low-income and at risk pregnant women); Increase the number of low-income children who receive regular health assessments and, follow-up diagnostic and treatment services; Provide access to preventive and primary care services for low income children as well as rehabilitative services for children with special health needs; Implement family-centered, community-based, systems of coordinated care for CSHCN; and Provide toll-free hotlines and assistance with applying for services to pregnant women with infants and children who are eligible for Title XIX (Medicaid).
* Attend Grants Management Training * Administrative Requirements * Policies, Regulations & Guidance * Frequently Asked Questions ### Become a grant reviewer * Register as a HRSA grant reviewer") * Learn about the grant review process Find a Medically Underserved Area HRSA Health Resources and Services Administration Facebook")X")YouTube")LinkedIn")Instagram") * Freedom of Information Act * Health and Human Services") ## Parents: don’t struggle alone The National Maternal Mental Health Hotline provides free, confidential mental health support.
Moms and new parents can call or text any time, every day. **Start a call:** 1-833-TLC-MAMA (1-833-852-6262) **Text now:** 1-833-TLC-MAMA (1-833-852-6262) **Use TTY:** Use your preferred relay service or dial 711, then 1-833-852-6262. **Learn more about the Hotline**
According to the current listing, eligibility includes: Nonprofits, universities, and state/local governments. Confirm the full requirements in the official notice before applying.
Applications for Maternal and Child Health Services are due July 13, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Maternal and Child Health Services is funded by HRSA Maternal & Child Health Bureau. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Nevada. If your organization operates elsewhere, check the official notice for location requirements.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.
Tennessee's $206.9M RHTP allocation begins distribution with a 30-day virtual maternal/child mental health consultation grant. The state plans a new opportunity every Friday — the cadence and structure here are the blueprint for how the $50B nationwide program rolls out.
Read articleNICHD's FY2026 funding strategy applies an automatic 14 percent reduction to every new R01 below the peer-review recommended level, eliminates inflationary increases on future-year commitments, and abandons a fixed payline entirely in favor of priority-driven discretion. The structural implications for child health investigators.
Read articleWhile science funding cuts dominate headlines, the FY2027 budget proposes a $15.8 billion cut to HHS, eliminates hospital preparedness and family planning programs, cuts CDC by $3 billion, and consolidates behavioral health grants into a $4.5 billion mega-block-grant. The definitive breakdown for public health grant seekers.
Read article